Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:748 (25 September), doi:10.1136/bmj.329.7468.748
Did major media outlets fail to ask the right questions about depression study?
| The first 150 words of the full text of this article appear below. |
Recent headlines announcing the results of a US study of clinically depressed adolescents were unequivocal: "Talk and pills best for depression in kids" (CNN.com); "Prescribed drugs with therapy aid teen depression" (Wall Street Journal); "Combination aids depressed youths" (New York Times); and "Prozac plus talk is best for teen depression" (Washington Post).
The headlines were matched by the exuberant claim of the study researchers who said that 71% of teenagers treated with a combination of fluoxetine (Prozac) and cognitive behaviour therapy improvedcompared with only 35% of teens treated with placebo alone. That claim, published last month (
JAMA
2004;292: 807-20
But several points that might concern both laypeople and scientists went unreported by the New York
Jeanne Lenzer, medical investigative journalist
Kingston, New York state, USA jeanne.lenzer@verizon.net
Read all Rapid Responses